Jun 19, 2009 by Robert SteyerMannKind Needs More LeapsGetting FDA approval for its inhaled-insulin product is only one hurdle for this start-up.
Jun 17, 2009 by Robert SteyerSmall Caps, Big RiskSmall-cap gambling companies present investors with similar risks to their big brothers.
Jun 3, 2009 by Robert SteyerAre China's Casinos a Better Investment?Do China-based companies offer investors a home-field advantage in Macau's gambling business?
Jun 1, 2009 by Robert SteyerGambling's China SyndromeCasino operators must balance Macau's lure of big profits with thorny local politics.
May 28, 2009 by Robert SteyerFighting an Incurable DiseaseUnited Therapeutics battles drug giants in a specialized blood-pressure treatment arena.
May 22, 2009 by Robert SteyerMotor-Sports Stocks StallHit hard by the recession, auto racetrack companies try to fix their financial flat tires.
May 21, 2009 by Robert SteyerThe AstraZeneca DilemmaCan the European giant produce enough new drugs to offset a series of upcoming patent expirations?
May 13, 2009 by Robert SteyerMGM Mirage Rides the WaiveThe casino operator buys more time thanks to another deal with its lenders.
May 11, 2009 by Robert SteyerVacillating Las VegasShares of Las Vegas casino operators don't need much news to rise or fall dramatically -- but how long can this last?
May 6, 2009 by Robert SteyerGetting Ahead by Getting Rid of WrinklesMedicis gets the FDA OK for an anti-wrinkle product as the market for Botox and other cosmetic skin drugs sags.
May 5, 2009 by Robert Steyersanofi-aventis' To-Do ListThe French drugmaker seeks acquisitions to reinforce and expand its business geographically and scientifically.
May 4, 2009 by Robert SteyerCasino Companies' Comeback?Three gambling operators post Wall Street-beating quarterly results -- without doing business in Las Vegas.
May 4, 2009 by Robert SteyerBeyond Provenge -- The Next Hot Cancer Drug?The search for prostate cancer treatments is filled with prospects and littered with failures.
Apr 27, 2009 by Robert SteyerGambling Execs Exit; Should Investors Follow?Top officials are leaving as casino and racetrack companies continue to struggle.
Apr 24, 2009 by Robert SteyerNothing to CRO AboutContract research organizations experience that sickening feeling.
Apr 22, 2009 by Robert SteyerMGM Mirage Binges and PurgesThe casino company stuffs itself with debt, making long-term investors sick.
Apr 17, 2009 by Robert SteyerThe Steady BAX BeatBaxter International's diversity continues to produce prosperity.
Mar 24, 2009 by Robert SteyerRacing for More RevenueChurchill Downs seeks additional gambling opportunities.
Mar 24, 2009 by Robert SteyerDrugmakers Diversify -- AgainMerck and Pfizer choose businesses they once eschewed.
